Navigation Links
Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
Date:6/12/2008

Reports Full Assessment of Data from Positive Phase 2a Trial

WALTHAM, Mass., June 12 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today announced that based on feedback from the Food and Drug Administration, the Company plans to initiate a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar disorder later this year. This will be a multi-center, parallel arm placebo-controlled, clinical trial in which approximately 150 patients with bipolar disorder will receive either RG2417 or a placebo twice a day for eight-weeks. This study is designed to assess the efficacy and safety of RG2417 on the symptom of depression as measured by the Montgomery-Asberg Depression Rating Scale (MADRS). Gary S. Sachs, M.D., founder and director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital and an Associate Professor of Psychiatry at the Harvard Medical School will be the Principal Investigator of this study.

Repligen previously reported positive initial results from a Phase 2a clinical trial of RG2417 in patients with bipolar disorder. We have now completed our assessment of the data and have found that patients with a history of more frequent symptoms demonstrated greater improvements when treated with RG2417 than patients without a history of frequent symptoms. For example, patients with more than 5 episodes of depression over their entire life (n=50) demonstrated greater improvements in their symptoms of depression compared to patients with 5 or fewer lifetime episodes of depression. From weeks 2-6 of treatment, the patients with more than 5 lifetime episodes of depression who received RG2417 had an average improvement on MADRS of 5.5 points over place
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
2. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
3. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... of Powers Lake, Wisconsin , ... a distribution and co-marketing agreement allowing ScriptPro to ... throughout the United States . ... management and workflow systems to retail and ambulatory ...
(Date:7/25/2014)... 25, 2014  CVS Caremark Corporation (NYSE: ... Tuesday, August 5, 2014, at 8:30 a.m. (EDT) with ... financial results. An audio webcast of the ... Relations portion of the CVS Caremark website for all ... . This webcast will be archived and available on ...
(Date:7/25/2014)... OF SPAIN, Trinidad and Tobago , July ... Division of the Trinidad & Tobago Ministry of ... market, an innovative therapy that significantly increases the cure ... for patients infected with the genotype 1 virus. ... under the trade brand INCIVO®. ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
(Date:7/26/2014)... 2014 According to the Metabolic Enhancement ... a comprehensive bodybuilding program that helps men lose body ... steroids . The program also instructs men how to ... , Vkool reveals in its review that this program ... help men get ripped and jacked at the same ...
(Date:7/25/2014)... Staffordshire, UK (PRWEB) July 26, 2014 ... a variety of dental services including general dentistry, clear ... practice opening in September this year in Derby. The ... is at the HollyBrook Medical Centre in Littleover, Derby. ... the new practice. , The new dental practice, which ...
(Date:7/25/2014)... According to a new market ... (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, ... and Geography - Global Forecast to 2014 - ... market is expected to reach $2.50 at a ... Browse 117 market data Tables and 57 Figures ...
(Date:7/25/2014)... New York, NY (PRWEB) July 25, 2014 ... cut ticket prices across the board for the Guinness ... Liverpool FC and Olympiacos FC at Soldier Field ... is also offering their customer appreciation promo/coupon/offer code SOCCER-2014 ... be an amazing year for diehard soccer fans in ...
(Date:7/25/2014)... USA (PRWEB) July 25, 2014 As reported ... Use, OD Deaths Increase (7/20), Michigan has seen a nearly ... four years. While the count was 271 between 1999 and ... range. DEA Agents believe that, like other states, drug users ... the drug via prescription pills. He compared the price of ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2
... anxiety experienced by many women after a miscarriage can continue ... according to a study led by University of Rochester Medical ... Journal of Psychiatry . "Our study clearly shows that ... mental health problems that many women experience after a miscarriage ...
... end-stage renal disease who opt for peritoneal dialysis experience no ... a retrospective study at UT Southwestern Medical Center has found. ... body and provides greater mobility than hemodialysis, the more common ... peritoneal dialysis, have a better quality of life and the ...
... of HIV-infected mothers a daily dose of the antiretroviral ... HIV transmission to the infants at age 6 months ... weeks, according to preliminary clinical trial data presented today. ... reduction in HIV transmission risk through breast milk for ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... Drug Administration said Wednesday that it plans to remove ... from pharmacy shelves. These drugs have not been ... they may be riskier to take than approved over-the-counter ...
... , WEDNESDAY, March 2 (HealthDay News) -- Moms-to-be ... oxycodone (Oxycontin) may increase the risk of birth ... report. Taking these types of analgesics just prior to ... to a modest risk of congenital heart defects in an ...
... Tobacco smoking is the leading preventable cause of death and ... year attributable to smoking or its consequences. And yet teens ... and approximately 80 percent of adult smokers became hooked by ... up smoking usually never do. While studies ...
Cached Medicine News:Health News:Women who miscarry continue to have mental health problems 2Health News:Portable, less costly peritoneal dialysis shows no additional catheter risk factors 2Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 2Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 3Health News:FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds 2Health News:FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds 3Health News:CDC Links Prescription Painkillers in Pregnancy to Birth Defects 2Health News:Tobacco smoking impacts teens' brains, UCLA study shows 2Health News:Tobacco smoking impacts teens' brains, UCLA study shows 3
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... Only 1-2% of circulating testosterone exists as ... 60%, is bound to SHBG with high ... bound to albumin. Both the albumin-bound and ... SHBG effectively inhibits testosterone action. Measurement of ...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
Medicine Products: